BioBrick

Cultivarium and ATCC Support iGEM Teams Striving to Advance the Field of Synthetic Biology

Retrieved on: 
Tuesday, April 2, 2024
Agriculture, BioBrick, Synthetic biology, Education, College of Engineering (KNUST), Climate change, Health, Collection, International, Research, ATCC, Biotechnology, Creativity, Doctor of Philosophy

WATERTOWN, Mass. and MANASSAS, Va., April 2, 2024 /PRNewswire/ -- Cultivarium, the focused research organization creating open-source tools to expand access to uncharacterized microorganisms, and ATCC, the world's premier biological materials management and standards organization, today announced a groundbreaking collaboration to help iGEM 2024 teams access non-model microbes for biotechnology. The annual iGEM Competition involves multidisciplinary student teams from across the globe that compete for medals and awards by designing, building, and testing genetically engineered systems using standard biological parts called BioBricks. Working in and outside the lab, iGEM teams aim to create sophisticated synthetic biology projects that can positively contribute to their communities and the world.

Key Points: 
  • Working in and outside the lab, iGEM teams aim to create sophisticated synthetic biology projects that can positively contribute to their communities and the world.
  • Cultivarium and ATCC are committing to empowering the creativity of iGEM teams with diverse and innovative microbial resources to expand the horizons of synthetic biology research.
  • "By pairing Cultivarium's capabilities and ATCC's enormous and taxonomically diverse collection of microbes we can support iGEM teams to be bold, creative and drive breakthroughs in synthetic biology."
  • Together, Cultivarium and ATCC are poised to revolutionize the landscape of synthetic biology by equipping iGEM teams with the tools and resources needed to tackle global challenges and unlock the full potential of non-model microbes.

Global Synthetic Biology Market Report: Data from 2019 to 2021, and CAGR Projections through 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 10, 2022
Health, Biotechnology, Industry, Synthetic biology, Cosmetics, Health, Twist Bioscience, Agriculture, Merck Group, Liquid biopsy, GenScript Biotech, Thermo Fisher Scientific, Skin care, Agilent Technologies, Food, Oligonucleotide, DNA, Software, Eurofins Scientific, Gene editing, Growth, Vaccine, BioBrick, Fine chemical

The "Synthetic Biology: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Synthetic Biology: Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2021 to 2026.
  • The publisher examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries and software; as well as the agriculture; consumer products, cosmetics and skin care, food and beverage, healthcare and industrial chemicals enable product sectors.
  • Major players include Agilent Technologies Inc., Eurofins Scientific, GenScript, Merck KGaA, Novozymes A/S, Thermo Fisher Scientific Inc., and Twist Bioscience

BioBricks Foundation Announces Publication of OpenMTA in Nature Biotechnology

Retrieved on: 
Thursday, October 11, 2018
Biology, Synthetic biology, BioBrick, Technology, Biotechnology, Drew Endy, Stanford University, Kahl

The OpenMTA launches today with a commentary published in the journal Nature Biotechnology.

Key Points: 
  • The OpenMTA launches today with a commentary published in the journal Nature Biotechnology.
  • The agreement was developed through a collaboration led by the San Francisco-based BioBricks Foundation and the UK-based OpenPlant Synthetic Biology Research Centre.
  • Dr. Linda Kahl, Senior Counsel of the BioBricks Foundation, said: "We encourage organizations worldwide to sign the OpenMTA Master Agreement and start using it.
  • Drew Endy, President of the BioBricks Foundation and Professor at Stanford University, noted: "The OpenMTA provides a permissive foundation supporting many communities and interests.